Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Voyager Therapeutics, Inc. - Common Stock (NQ:VYGR)

4.005 -0.255 (-5.99%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 9, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 557,313
Open 4.260
Bid (Size) 4.000 (5)
Ask (Size) 4.020 (5)
Prev. Close 4.260
Today's Range 3.910 - 4.275
52wk Range 2.645 - 8.275
Shares Outstanding 55,434,956
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Friday's After-Market Session
 
Via Benzinga
7 Analysts Assess Voyager Therapeutics: What You Need To Know
 
Via Benzinga

Performance

YTD
-32.9%
-32.9%
1 Month
+30.0%
+30.0%
3 Month
+19.6%
+19.6%
6 Month
-4.0%
-4.0%
1 Year
-35.3%
-35.3%

More News

Read More
Bragar Eagel & Squire, P.C. Is Investigating Dave, Red Cat, Perpetua, and Voyager and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
A Glimpse Into The Expert Outlook On Voyager Therapeutics Through 4 Analysts
Via Benzinga
A Glimpse Into The Expert Outlook On Voyager Therapeutics Through 5 Analysts
Via Benzinga
Voyager Therapeutics Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)
Via Benzinga
Earnings Scheduled For November 12, 2024
Via Benzinga
Earnings Scheduled For March 11, 2025
Via Benzinga
VOYAGER ALERT: Bragar Eagel & Squire, P.C. is Investigating Voyager Therapeutics, Inc. on Behalf of Voyager Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Preview: Voyager Therapeutics's Earnings
Via Benzinga
In-Depth Examination Of 4 Analyst Recommendations For Voyager Therapeutics
Via Benzinga
VYGR Investors Have Opportunity to Join Voyager Therapeutics, Inc. Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Get “Picky” With Stocks For September Profits
Via Talk Markets
3 High-Growth Stocks Poised To Double By Next Year
Via Talk Markets
What Analysts Are Saying About Voyager Therapeutics Stock
Via Benzinga
Is VOYAGER THERAPEUTICS INC (NASDAQ:VYGR) suited for growth investing?
Via Chartmill
Is NASDAQ:VYGR a Fit for Growth Investing Strategies?
Via Chartmill
7 Biotech Stocks to Buy for Their Game-Changing Potential
Via InvestorPlace
VYGR Stock Earnings: Voyager Therapeutics Beats EPS, Beats Revenue for Q2 2024
Via InvestorPlace
VYGR Stock Earnings: Voyager Therapeutics Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
The Healthcare Bargain Blitz: 7 Undervalued Stocks to Inject into Your Portfolio
Via InvestorPlace
Delving into NASDAQ:VYGR's Growth Prospects.
Via Chartmill
Cheap Thrills: 7 Promising Value Stocks You Can Buy for Under $20
Via InvestorPlace
Analyst Bullish On Gene Therapy-Focused Voyager Therapeutics Sees Best In Class Potential For Its Neurogenetic Medicine Platform
Via Benzinga

Frequently Asked Questions

Is Voyager Therapeutics, Inc. - Common Stock publicly traded?
Yes, Voyager Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Voyager Therapeutics, Inc. - Common Stock trade on?
Voyager Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Voyager Therapeutics, Inc. - Common Stock?
The ticker symbol for Voyager Therapeutics, Inc. - Common Stock is VYGR on the Nasdaq Stock Market
What is the current price of Voyager Therapeutics, Inc. - Common Stock?
The current price of Voyager Therapeutics, Inc. - Common Stock is 4.005
When was Voyager Therapeutics, Inc. - Common Stock last traded?
The last trade of Voyager Therapeutics, Inc. - Common Stock was at 09/09/25 04:00 PM ET
What is the market capitalization of Voyager Therapeutics, Inc. - Common Stock?
The market capitalization of Voyager Therapeutics, Inc. - Common Stock is 222.02M
How many shares of Voyager Therapeutics, Inc. - Common Stock are outstanding?
Voyager Therapeutics, Inc. - Common Stock has 222M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.